“Every Four Weeks, 10% Less Chance”
In 2019, a BMJ systematic review (34 studies, 1.72 million patients) reached a sobering conclusion: Every 4-week delay in cancer treatment increases mortality risk by approximately 10%.
For a head and neck cancer patient waiting 6 weeks for NHS radiotherapy, that’s roughly 15% increased mortality risk. In 2024/25, nearly 30,000 cancer patients waited over 104 days — over 14 weeks, four “every-4-week” cycles.
1. NHS Cancer Wait Data
Three Core Targets, Two Failed
| Target | Standard | 2024/25 Performance | Status |
|---|---|---|---|
| 28-day faster diagnosis | 75% | 80.2% | ✅ Met |
| Treatment within 31 days of decision | 96% | ~94% | ❌ Missed |
| Treatment within 62 days of referral | 85% | Only 3/121 trusts met | ❌ Severe failure |
Source: [BBC, “Nearly all NHS hospitals missing cancer targets”](https://www.bbc.co.uk/news/articles/cgjdpqvpj3lo)
2024/25 Key Figures
Over 100,000 patients failed to start treatment within 62 daysNearly 30,000 patients waited over 104 days (3.5 months)Operation cancellations requiring >28 days to reschedule — triple the 2015/16 levelLung cancer patients not treated within 62 days — up 40% since 2019---
2. The Cost of Delay
| Cancer Type | Treatment | Impact of 4-Week Delay |
|---|---|---|
| Head & Neck | Radiotherapy | 6-week wait: ~15% reduction in 5-year local control |
| Lung | Surgery | >8 weeks: significantly higher recurrence |
| Colorectal | Surgery | Increased early→advanced progression risk |
| Breast | Surgery | 8-week delay: reduced survival |
| Bladder | Radical cystectomy | >12 weeks: tumor stage progression |
Note: Based on clinical observations reported by RCR (Royal College of Radiologists) and Radiotherapy UK.
“My Cancer Went From Stage 1 to Stage 3”
The Guardian, June 2025: “In June 2024, I was diagnosed with colon cancer stage 1. Treatment should have started within 8 weeks. By November — 5 months later — I saw my surgeon. The tumor had progressed from stage 1 to stage 3.”
9/10 cancer center chiefs reported patients were delayed starting treatment in 2024; 7/10 said workforce gaps put patient safety at risk.
Source: [The Guardian, “People with cancer face ticking timebomb”](https://www.theguardian.com/society/2025/jun/05/people-with-cancer-face-ticking-timebomb-due-to-nhs-staff-shortages)
3. Why the Delays?
1. Severe Radiologist Shortage
RCR describes it as a “ticking timebomb.” All radiology departments could not scan all patients on time in 2024. Equipment aging — some machines are over 10 years past their intended lifespan.
2. NICE Approval Bottleneck
Median MHRA-to-NICE decision time increased from 137 days (2021) to 302 days (2023). Only ~40% of new cancer drugs received positive NHS England recommendations.
Even FDA and MHRA-approved drugs may be unavailable to NHS patients — or require over a year of waiting.
3. Demand Exceeding Capacity
Aging population, COVID-19 backlog, shortage of specialist nurses and anesthesiologists.
4. Three Options
Option 1: Keep Waiting
Cost: ~10% increased mortality risk per 4-week delay. Cancer may progress.
Option 2: UK Private Care
Cost: CAR-T at £200,000+; immunotherapy at global prices — nearly as expensive as the US.
Option 3: Treatment in China Through mymedvia
Benefits:
⏱️ Treatment within 2 weeks, not 3-6 months💰 CAR-T: 1/3 of US price; immunotherapy: ~1/5 of US price🏥 China’s top cancer centers in Nature Index Global Top 100📋 Clear treatment plan and costs---
5. mymedvia Cancer Fast-Track
Day 1 → Contact us, provide medical records and diagnosis Day 1-3 → Chinese oncology expert team assessment, treatment recommendation Day 3-7 → Confirm treatment plan, cost details Day 7-14 → Fly to China, begin treatment
From first contact to treatment start — typically 1-2 weeks.
6. Scenarios Best Suited for China
| Best suited | Consider carefully |
|---|---|
| ✅ NHS wait >62 days, no clear start date | ⚠️ Requires ICU-level immediate care |
| ✅ NHS rejected a new drug | ⚠️ Drug not available in China either |
| ✅ US prices unaffordable | ⚠️ Medically unable to fly |
| ✅ Needs CAR-T therapy | ⚠️ Condition extremely unstable |
| ✅ Targeted drug 50%-80% cheaper in China |
7. FAQs
Q: What do I need to bring?
Related Articles
Learn more about [why choose China for cancer treatment](https://mymedvia.com/cancer-treatment-in-china/why-choose-china-for-cancer-treatment-2026-complete-guide/) and [top cancer hospitals in China](https://mymedvia.com/cancer-treatment-in-china/top-cancer-hospitals-in-china-2026-guide-for-international-patients/).
A: Pathology report, imaging files, previous treatment records, genetic testing reports, passport (we assist with visa). China’s top cancer centers re-examine all pathology and imaging to ensure accuracy.
Q: What about language?
A: PUMCH, Fudan Cancer Center, and Cancer Hospital CAMS all have international departments with English services. mymedvia Full Medical Concierge includes professional medical translation.
Q: How long must I stay?
A: Radiotherapy: 4-6 weeks; CAR-T: 5-7 weeks; surgery: 2-4 weeks. Immuno/targeted: first cycle within 1-2 weeks; subsequent cycles can be done at home.
8. Time Is Life
If you or a family member are experiencing:
“I’ve waited 3 months and the NHS says to wait longer”“My doctor recommended a new drug but NHS won’t approve it”“US treatment costs are astronomical”“Every day I wait, I worry more — has it spread?”Contact mymedvia through our website. We’ll provide a clear treatment recommendation within 24 hours.
Don’t wait. Every day counts.
mymedvia — Cancer treatment should never be delayed.
